The FDA-approved, targeted radiopharmaceutical agent can contribute to a patient’s cumulative radiation exposure.
Stephanie Trexler, PharmD, BCOP
Advertisement
Articles by Stephanie Trexler, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Medicare Is Finally Covering GLP-1s for Weight Loss: What the Bridge Program Means for Your Practice
2
Beyond Injections: The Rise of Oral GLP-1 Therapy
3
Updated 2025-2026 COVID-19 Vaccine Nearly Halved ED Visits, Hospitalizations in CDC-Funded Study
4
Cenrifki Becomes First EU-Approved Therapy Targeting Disability Progression in Nonrelapsing SPMS
5